MiR-520h is crucial for DAPK2 regulation and breast cancer progression

C. M. Su, M. Y. Wang, C. C. Hong, H. A. Chen, Y. H. Su, C. H. Wu, M. T. Huang, Y. W. Chang, S. S. Jiang, S. Y. Sung, J. Y. Chang, L. T. Chen, P. S. Chen, J. L. Su

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are small RNAs that suppress gene expression by their interaction with 3'untranslated region of specific target mRNAs. Although the dysregulation of miRNAs has been identified in human cancer, only a few of these miRNAs have been functionally documented in breast cancer. Thus, defining the important miRNA and functional target involved in chemoresistance is an urgent need for human breast cancer treatment. In this study, we, for the first time, identified a key role of miRNA 520h (miR-520h) in drug resistance. Through protecting cells from paclitaxel-induced apoptosis, expression of miR-520h promoted the drug resistance of human breast cancer cells. Bioinformatics prediction, compensatory mutation and functional validation further confirmed the essential role of miR-520h-suppressed Death-associated protein kinase 2 (DAPK2) expression, as restoring DAPK2 abolished miR-520h-promoted drug resistance, and knockdown of DAPK2 mitigated cell death caused by the depletion of miR-520h. Furthermore, we observed that higher level of miR-520h is associated with poor prognosis and lymph node metastasis in human breast cancer patients. These results show that miR-520h is not only an independent prognostic factor, but is also a potential functional target for future applications in cancer therapeutics.

Original languageEnglish
Pages (from-to)1134-1142
Number of pages9
JournalOncogene
Volume35
Issue number9
DOIs
Publication statusPublished - 2016 Mar 3

Fingerprint

Death-Associated Protein Kinases
MicroRNAs
Breast Neoplasms
Drug Resistance
3' Untranslated Regions
Paclitaxel
Computational Biology

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Su, C. M., Wang, M. Y., Hong, C. C., Chen, H. A., Su, Y. H., Wu, C. H., ... Su, J. L. (2016). MiR-520h is crucial for DAPK2 regulation and breast cancer progression. Oncogene, 35(9), 1134-1142. https://doi.org/10.1038/onc.2015.168
Su, C. M. ; Wang, M. Y. ; Hong, C. C. ; Chen, H. A. ; Su, Y. H. ; Wu, C. H. ; Huang, M. T. ; Chang, Y. W. ; Jiang, S. S. ; Sung, S. Y. ; Chang, J. Y. ; Chen, L. T. ; Chen, P. S. ; Su, J. L. / MiR-520h is crucial for DAPK2 regulation and breast cancer progression. In: Oncogene. 2016 ; Vol. 35, No. 9. pp. 1134-1142.
@article{24cfb1eccd554f62adf944e1b341a38b,
title = "MiR-520h is crucial for DAPK2 regulation and breast cancer progression",
abstract = "MicroRNAs (miRNAs) are small RNAs that suppress gene expression by their interaction with 3'untranslated region of specific target mRNAs. Although the dysregulation of miRNAs has been identified in human cancer, only a few of these miRNAs have been functionally documented in breast cancer. Thus, defining the important miRNA and functional target involved in chemoresistance is an urgent need for human breast cancer treatment. In this study, we, for the first time, identified a key role of miRNA 520h (miR-520h) in drug resistance. Through protecting cells from paclitaxel-induced apoptosis, expression of miR-520h promoted the drug resistance of human breast cancer cells. Bioinformatics prediction, compensatory mutation and functional validation further confirmed the essential role of miR-520h-suppressed Death-associated protein kinase 2 (DAPK2) expression, as restoring DAPK2 abolished miR-520h-promoted drug resistance, and knockdown of DAPK2 mitigated cell death caused by the depletion of miR-520h. Furthermore, we observed that higher level of miR-520h is associated with poor prognosis and lymph node metastasis in human breast cancer patients. These results show that miR-520h is not only an independent prognostic factor, but is also a potential functional target for future applications in cancer therapeutics.",
author = "Su, {C. M.} and Wang, {M. Y.} and Hong, {C. C.} and Chen, {H. A.} and Su, {Y. H.} and Wu, {C. H.} and Huang, {M. T.} and Chang, {Y. W.} and Jiang, {S. S.} and Sung, {S. Y.} and Chang, {J. Y.} and Chen, {L. T.} and Chen, {P. S.} and Su, {J. L.}",
year = "2016",
month = "3",
day = "3",
doi = "10.1038/onc.2015.168",
language = "English",
volume = "35",
pages = "1134--1142",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "9",

}

Su, CM, Wang, MY, Hong, CC, Chen, HA, Su, YH, Wu, CH, Huang, MT, Chang, YW, Jiang, SS, Sung, SY, Chang, JY, Chen, LT, Chen, PS & Su, JL 2016, 'MiR-520h is crucial for DAPK2 regulation and breast cancer progression', Oncogene, vol. 35, no. 9, pp. 1134-1142. https://doi.org/10.1038/onc.2015.168

MiR-520h is crucial for DAPK2 regulation and breast cancer progression. / Su, C. M.; Wang, M. Y.; Hong, C. C.; Chen, H. A.; Su, Y. H.; Wu, C. H.; Huang, M. T.; Chang, Y. W.; Jiang, S. S.; Sung, S. Y.; Chang, J. Y.; Chen, L. T.; Chen, P. S.; Su, J. L.

In: Oncogene, Vol. 35, No. 9, 03.03.2016, p. 1134-1142.

Research output: Contribution to journalArticle

TY - JOUR

T1 - MiR-520h is crucial for DAPK2 regulation and breast cancer progression

AU - Su, C. M.

AU - Wang, M. Y.

AU - Hong, C. C.

AU - Chen, H. A.

AU - Su, Y. H.

AU - Wu, C. H.

AU - Huang, M. T.

AU - Chang, Y. W.

AU - Jiang, S. S.

AU - Sung, S. Y.

AU - Chang, J. Y.

AU - Chen, L. T.

AU - Chen, P. S.

AU - Su, J. L.

PY - 2016/3/3

Y1 - 2016/3/3

N2 - MicroRNAs (miRNAs) are small RNAs that suppress gene expression by their interaction with 3'untranslated region of specific target mRNAs. Although the dysregulation of miRNAs has been identified in human cancer, only a few of these miRNAs have been functionally documented in breast cancer. Thus, defining the important miRNA and functional target involved in chemoresistance is an urgent need for human breast cancer treatment. In this study, we, for the first time, identified a key role of miRNA 520h (miR-520h) in drug resistance. Through protecting cells from paclitaxel-induced apoptosis, expression of miR-520h promoted the drug resistance of human breast cancer cells. Bioinformatics prediction, compensatory mutation and functional validation further confirmed the essential role of miR-520h-suppressed Death-associated protein kinase 2 (DAPK2) expression, as restoring DAPK2 abolished miR-520h-promoted drug resistance, and knockdown of DAPK2 mitigated cell death caused by the depletion of miR-520h. Furthermore, we observed that higher level of miR-520h is associated with poor prognosis and lymph node metastasis in human breast cancer patients. These results show that miR-520h is not only an independent prognostic factor, but is also a potential functional target for future applications in cancer therapeutics.

AB - MicroRNAs (miRNAs) are small RNAs that suppress gene expression by their interaction with 3'untranslated region of specific target mRNAs. Although the dysregulation of miRNAs has been identified in human cancer, only a few of these miRNAs have been functionally documented in breast cancer. Thus, defining the important miRNA and functional target involved in chemoresistance is an urgent need for human breast cancer treatment. In this study, we, for the first time, identified a key role of miRNA 520h (miR-520h) in drug resistance. Through protecting cells from paclitaxel-induced apoptosis, expression of miR-520h promoted the drug resistance of human breast cancer cells. Bioinformatics prediction, compensatory mutation and functional validation further confirmed the essential role of miR-520h-suppressed Death-associated protein kinase 2 (DAPK2) expression, as restoring DAPK2 abolished miR-520h-promoted drug resistance, and knockdown of DAPK2 mitigated cell death caused by the depletion of miR-520h. Furthermore, we observed that higher level of miR-520h is associated with poor prognosis and lymph node metastasis in human breast cancer patients. These results show that miR-520h is not only an independent prognostic factor, but is also a potential functional target for future applications in cancer therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=84959485225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959485225&partnerID=8YFLogxK

U2 - 10.1038/onc.2015.168

DO - 10.1038/onc.2015.168

M3 - Article

C2 - 25982274

AN - SCOPUS:84959485225

VL - 35

SP - 1134

EP - 1142

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 9

ER -

Su CM, Wang MY, Hong CC, Chen HA, Su YH, Wu CH et al. MiR-520h is crucial for DAPK2 regulation and breast cancer progression. Oncogene. 2016 Mar 3;35(9):1134-1142. https://doi.org/10.1038/onc.2015.168